|
Lung Cond. Medications Menopause Men's Health Mental Health Migraine Recipes Senior Health Skin Sleep Thyroid Women's Health 650+ More Topics Health Extras Q&A: Ask Our Health Experts a Question NOW » Find a Therapist » Google Refined Search » Topics Related to cefpodoxime proxetil-oral, Vantin Doctors' Views Generic Drugs, Are They As Good as Brand-Names? Drugs: The Most Common Medication Errors more » Health Facts Drug Name Confusion: Preventing Medication Errors cefpodoxime proxetil-oral Specialty RSS What is this? WebMD Daily Get breaking medical news. WebMD Privacy Policy Visit Thecefpodoxime proxetil-oral index New on MedicineNet Autism: Early Red Flags Zelnorm Back on Market Low Blood Pressure Heart Transplant Aortic Stenosis Symptoms Crohn's & Abdominal Pain Ask the Experts Daily Health News Why Do People Have Sex? 66 Million Donors Lost Laser Printer Risks Sleep Drugs for Kids? COPD: Gender Differences? Health News Feed Newsletter Signup Health
vantin drug =us-ascii">VANTIN - Drug - Image VANTINBrand NameGeneric IngredientsVANTINCEFPODOXIME PROXETILColorOrangeShapeOvalImprintU 3617ColorOrangeShapeEgg-shapeImprintU 3618& 169; All MICROMEDEX Systems are Copyright (C) 1974 - 2006 Thomson MICROMEDEX All rights reserved.& 160; Go to top of page& 160;This information is not intended to replace the advice of a doctor. Healthwise and Thomson Healthcare disclaim any liability for the decisions you make based on this information. For more information vantin drug, click here. How this information was developed.& 160; vantin drug.
vantin drug Y and may require colectomy. CDAD must be considered in all patients who present with diarrhea following antibiotic use. Careful medical history is necessary since CDAD has been reported to occur over two months after the administration of antibacterial agents. If CDAD is suspected or confirmed vantin drug, ongoing antibiotic use not directed against C. difficile mav need to be discontinued. Appropriate fluid and electrolyte management. Protein supplementation vantin drug, antibiotic treatment of C. difficile vantin drug, and surgical evaluation should be instituted as clinically indicated. A concerted effort to monitor for C. difficile in cefpodoxime-treated patients with diarrhea was undertaken because of an increased incidence of diarrhea associated with C. difficile in early trials in normal subjects. C. difficile organisms or toxin was reported in 10% of the cefpodoxime-treated adult patients with diarrhea; however vantin drug, no specific diagnosis of pseudomembranous colitis was made in these patients. In post-marketing exper.
vantin drug E proxetil equivalent to 100 mg or 200 mg of cefpodoxime activity and the following inactive ingredients: carboxymethylcellulose calcium vantin drug, carnauba wax vantin drug, TD&C Yellow No. 6 vantin drug, hydroxypropylcellulose vantin drug, hypromellose vantin drug, lactose hydrous vantin drug, magnesium stearate vantin drug, propylene glycol vantin drug, sodium lauryl sulfate and titanium dioxide. In addition vantin drug, the 100 mg film-coated tablets contain D&C Yellow No. 10 and the 200 mg film-coated tablets contain FD&C Red No. 40. Each 5 mL of VANTIN Oral Suspension contains cefpodoxime proxetil equivalent to 50 mg or 100 mg of cefpodoxime activity after constitution and the following inactive ingredients: artificial flavorings vantin drug, butylated hydroxy anisole (BHA) vantin drug, carboxymethylcellulose sodium vantin drug, microcrystalline cellulose vantin drug, carrageenan vantin drug, citric acid vantin drug, colloidal silicon dioxide vantin drug, croscarmellose sodium vantin drug, hydroxypropylcellulose vantin drug, lactose vantin drug, maltodextrin vantin drug, natural flavorings vantin drug, propylene glycol alginate vantin drug, sodium citrate vantin drug, sodium benzoate vantin drug, starch vantin drug, sucrose vantin drug, and vegetable oil. Next: Vantin - Cli.
vantin drug 
vantin drug | | | | | |
vantin drug
healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, direction
|
